Robert Malenka




Robert C. Malenka (born June 21, 1955) is a Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University. He is also the director of the Nancy Friend Pritzker Laboratory in the Stanford Medical Center.[1] He is a member of the National Academies of Sciences, Engineering, and Medicine, as well as the American Academy of Arts and Sciences.[2] Malenka's laboratory research with the National Alzheimer's Foundation has informed researchers aiming to find a neuronal basis for Alzheimer's disease.[3] Malenka's main career is focused on studying the mechanisms of synaptic plasticity and the effects of neural circuits on learning and memory.[4]




Contents






  • 1 Early years and education


  • 2 Career


  • 3 Professional organizations


  • 4 Publications


  • 5 Awards and honors


  • 6 Talks and interviews


  • 7 References





Early years and education


Robert Malenka grew up playing sports in the town of Belmont, Massachusetts. Malenka is still an avid tennis player and athletic spectator.[2] He grew up with his brother, David Malenka, who is currently practicing cardiology at the Dartmouth Hitchcock Medical Center in Hanover, New Hampshire. Malenka always had an interest in science, and while choosing a career path also considered being a neurosurgeon, neurologist, and clinical psychologist.[2]


For Malenka's undergraduate education, he attended Harvard University and graduated in 1978. After his graduation, Malenka received his MD and PhD from Stanford University in 1983.[4] While receiving these titles, he also completed his psychiatric residency at Stanford and a postdoctoral fellowship at the University of California, San Francisco.[2]



Career


Malenka has spent the last ten years in his lab identifying the mechanically distinct forms of synaptic plasticity present in the human brain.[4] His main goal was to distinctly separate the steps which lead to the varying forms of synaptic plasticity, while also identifying the proteins which contribute to the altering of synaptic efficacy over time.[4] As a side project in his laboratory, Malenka studies the effects that drugs like cocaine and amphetamine have on synaptic plasticity. In recent years, he has isolated a novel form of synaptic plasticity in the nucleus accumbens, the part of the brain associated with reward pathways.[4]



Professional organizations


Spanning from 1999 to 2008, Malenka served on the Society for Neuroscience's Programming Committee, the Renovis Incorporated Advisory Board, and the Merck Incorporated Advisory Board.[1]


He is currently on the Scientific Council for the Brain and Behavior Research Foundation, and is on the Board of Directors for the Brain Research Foundation.[1]


Malenka is also the co-founder of Circuit Therapeutics, Inc, a company which he began working with in 2012. Circuit Therapeutics uses optogenetic technology to target specific neurons in patients who suffer from chronic diseases and have damaged neuronal function.[5]



Publications


Malenka's work has been published in 274 papers.[6] One of his first major publications was in Neuron Magazine's inaugural issue, a paper in which he proposed that long-term potentiation at neuronal synapses must involve some postsynaptic modifications.[2]



Awards and honors


Robert Malenka's first major career award was the Young Investigator Award, given to him by the Society for Neuroscience in 1993.[1]


After graduation from Stanford Medical School, Malenka earned the Distinguished Alumni Award in 1998.[1] In that same year, Malenka earned the Daniel Efron Award, given to him by the American College of Neuropsychopharmacology.[1]


Malenka's first international award came in 2000, when he received the International Prize in Neuroscience from the Milena Kemali Foundation.[1]


Malenka is a two-time recipient of the Julius Axelrod Prize, one given as a mentorship award from the American College of Neuropsychopharmacology (2011), and the other given to him by the Society for Neuroscience in 2016.[7][1]



Talks and interviews


CSHL Leading Strand, June 2018[8]


World Economic Forum, February 2016[9]


USRP, July 2015[10]



References




  1. ^ abcdefgh "Stanford Medicine: CAP Profiles". Stanford Medicine. Retrieved June 10, 2018..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ abcde "Neuron Q&A: Robert Malenka" (PDF). CellPress. Retrieved June 14, 2018.


  3. ^ Nair, Prashant (2011-10-04). "QnAs with Robert C. Malenka". Proceedings of the National Academy of Sciences. 108 (40): 16501. doi:10.1073/pnas.1110807108. ISSN 0027-8424. PMC 3189022. PMID 21808027.


  4. ^ abcde "Robert Malenka - Professor of Psychiatry and Behavioral Sciences". Stanford Bio-X. Retrieved June 6, 2018.


  5. ^ "Circuit TX: The Team". Circuit Therapeutics. Circuit Therapeutics, Inc. Retrieved June 23, 2018.


  6. ^ "Robert C. Malenka - Publications". neurotree.org. Retrieved 2018-06-23.


  7. ^ "Julius Axelrod Prize". Society for Neuroscience. Retrieved June 14, 2018.


  8. ^ CSHL Leading Strand (2018-06-04), 83rd Symposium - Brains and Behavior - 01 - Robert Malenka, retrieved 2018-06-24


  9. ^ World Economic Forum (2016-02-19), Molecular mechanisms of reward and aversion | Robert Malenka, retrieved 2018-06-24


  10. ^ "USRP 2015 - Synaptic Plasticity: The Brain's Response to Experience | Welcome to Bio-X". biox.stanford.edu. Retrieved 2018-06-24.








-

這個網誌中的熱門文章

12.7 cm/40 Type 89 naval gun

圖片
12.7 cm/40 Type 89 naval gun Type 89 gun mounted on Chitose Type Naval gun anti-aircraft gun Place of origin Japan Service history In service 1932–45 Used by Imperial Japanese Navy Wars World War II Production history Designed 1928–32 Produced 1932–45 No.  built ~1500 Variants Type 88 Specifications Mass 3,100 kilograms (6,834 lb) Barrel length 5,080 millimeters (16 ft 8 in) (bore length) Shell Fixed Shell weight 20.9–23.45 kilograms (46.1–51.7 lb) Caliber 12.7-centimeter (5.0 in) Breech horizontal breech block Elevation -8° to +90° [1] Rate of fire 8-14 rounds per minute Muzzle velocity 720–725 meters per second (2,360–2,380 ft/s) Maximum firing range 9,440 meters (30,970 ft) at 90° (AA ceiling) 14,800 meters (48,600 ft) at 45° The 12.7 cm/40 Type 89 naval gun was a Japanese anti-aircraft (AA) gun introduced before World War II. It was the Imperial Japanese Navy's standard heavy AA
閱讀完整內容

Shark

圖片
For other uses, see Shark (disambiguation). Sharks Temporal range: Ludfordian-Present, 425–0 Ma PreЄ Є O S D C P T J K Pg N [1] Clockwise from top left: spiny dogfish, Japanese sawshark, whale shark, great white shark, horn shark, frilled shark, scalloped hammerhead and Australian angelshark representing the orders Squaliformes, Pristiophoriformes, Orectolobiformes, Lamniformes, Heterodontiformes, Hexanchiformes, Carcharhiniformes and Squatiniformes respectively. Scientific classification Kingdom: Animalia Phylum: Chordata Class: Chondrichthyes Subclass: Elasmobranchii Infraclass: Euselachii Superorder: Selachimorpha Orders Carcharhiniformes Heterodontiformes Hexanchiformes Lamniformes Orectolobiformes Pristiophoriformes Squaliformes Squatiniformes † Cladoselachiformes † Hybodontiformes † Symmoriida † Xenacanthida (Xenacantiformes) † Elegestolepis † = extinct Synonyms Pleurotremata Sharks
閱讀完整內容

Wiciokrzew

圖片
Wiciokrzew, suchodrzew Morfologia (wiciokrzew pospolity) Systematyka [1] Domena eukarionty Królestwo rośliny Klad rośliny naczyniowe Klad rośliny nasienne Klasa okrytonasienne Klad astrowe Rząd szczeciowce Rodzina przewiertniowate Rodzaj wiciokrzew Nazwa systematyczna Lonicera L. Sp. Pl. 173. 1 Mai 1753 Typ nomenklatoryczny Lonicera caprifolium L. [2] Multimedia w Wikimedia Commons Hasło w Wikisłowniku Kwiaty suchodrzewu pospolitego Owoce suchodrzewu pospolitego Kwiaty wiciokrzewu pomorskiego Kwiaty wiciokrzewu przewiercienia Wiciokrzew , suchodrzew ( Lonicera L.) – rodzaj roślin wieloletnich należący do rodziny przewiertniowatych ( Caprifoliaceae ). Rośliny zielne i pnące nazywane są wiciokrzewami, natomiast krzewy i niewielkie drzewa – suchodrzewami. Rodzaj liczy około 180 gatunków szeroko rozprzestrzenionych na całej półkuli północnej [3] [4]
閱讀完整內容